Dr. Claudia Quezada

Dr. Flavio Salazar Onfray is a biologist from the University of Uppsala, Sweden. He obtained his Ph.D. from the Karolinska Institute. He works in the Disciplinary Program of Immunology at the Institute of Biomedical Sciences in the Faculty of Medicine, University of Chile. Dr. Salazar’s interest has been focused on several aspects of tumor immunology, from basic research to clinical trials. Dr. Salazar led a multidisciplinary group that performed Phase I and Phase I/II clinical trials in Chile on cancer immunotherapy. From 2005 to 2022, he was Deputy Director of the Institute Millennium of Immunology and Immunotherapy. Dr. Salazar is a former president of the Chilean Society of Immunology and a past president of the Latin American Association of Immunology Societies (ALAI). He founded two spinoff companies, Oncobiomed in 2002, dedicated to cellular immunotherapy technology transfer, and Bionex in 2007, dedicated to advising basic scientists in designing R&D applications. From 2014 to March 2022, he was Vice President of Research and Development at the University of Chile. He was Minister of Science, Technology, Knowledge, and Innovation from March to September 2022.